Bookmark

Add to MyYahoo RSS

Spectrum Pharmaceuticals News

News on Spectrum Pharmaceuticals (Ticker: SPPI) continually updated from thousands of sources around the net.

Tuesday Apr 15 | Sys-Con Media

Analysts View on Biotech Equities -- Research on Organovo Holdings,...

The gains were broad based as all the sectors ended the session in positive. The S&P 500 Health Care Sector Index ended the day at 648.05, up 0.51%, while the same has fallen by 1.86% in the previous three months.

Comment?

Related Topix: Startups, BioMarin Pharmaceutical, Biotech, Vertex Pharmaceuticals, Medicine, Healthcare Industry, Vertex, Financial Markets

Tue Apr 08, 2014

Business Wire

Press release distribution, EDGAR filing, XBRL, regulatory filings

In first quarter 2014, ... )--Government Properties Income Trust today announced its regular quarterly common share distribution of $0.43 per common share .

Comment?

Related Topix: Startups, Rambus, Inventions, Science / Technology, Biotech, Medicine, Healthcare Industry

Business Wire

View Press Release

If you own common stock in Spectrum Pharmaceuticals, Inc. and wish to obtain additional information, please contact Eduard Korsinsky, Esq.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, New York

MarketWatch

Stock market live blog: S&P 500 breaks 3-day skid; Google, Yahoo, eBay rally

Rajesh C. Shrotriya, chairman and chief executive of Spectrum Pharmaceuticals, says with conviction that a lot of biotech shares are overvalued because, simply put, they've been "selling a dream" instead of focusing on fundamentals.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Financial Markets

Mon Apr 07, 2014

AmericanBankingNews.com

Spectrum Pharmaceuticals Downgraded by TheStreet to "Sell"

The analysts wrote, "Spectrum Pharmaceuticals has been downgraded by TheStreet Ratings from hold to sell.

Comment?

Related Topix: Biotech, Healthcare Industry

Tue Apr 01, 2014

Bangor Daily News

Varney Agency hires Lee Rossignol, director of sales

Varney Agency is pleased to announce the hiring of Lee Rossignol, director of sales.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Sales, Marketing, University of Maine, Winslow, ME, Gorham, ME

Thu Mar 27, 2014

Hispanic Business

Topotarget announces financial results for the year ended Dec 31, 2013

A net loss in continued operations of ). Revenues are composed of milestone payments from the renegotiated agreement with Apricus Biosciences, Inc. and income per our collaboration agreement with Spectrum Pharmaceuticals.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry

Wed Mar 26, 2014

GlobeNewswire

Topotarget confirms receipt of acceptance-to-file milestone payment

Topotarget A/S hereby confirms the receipt of the milestone payment of USD 10 million and 1 million shares from Spectrum Pharmaceuticals, Inc. related to the US Food and Drug Administration's recent acceptance to file BeleodaqTM for peripheral T-cell lymphoma .

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Food and Drug Administration, Lymphoma, Health, Oncology, Sarcoma

Thu Mar 20, 2014

GlobeNewswire

Teleconference regarding annual report 2013

Topotarget announces that a teleconference regarding the Company's annual report 2013 will be held on March 27, 2014 at 2:00 pm CET.

Comment?

Related Topix: World News, Denmark, Biotech, Medicine, Healthcare Industry

Wed Mar 19, 2014

BioSpace

Mountain View's Anacor Pharmaceuticals, Inc. Finds Its New CEO

Anacor Pharmaceuticals Appoints Paul L. Berns as Chief Executive Officer PALO ALTO, Calif.-- -- Anacor Pharmaceuticals, Inc. today announced that the Company's Board of Directors has appointed Paul L. Berns, Anacor's Chairman of the Board of Directors, to assume the role of President and Chief Executive Officer, effective immediately.

Comment?

Related Topix: Palo Alto, CA, Biotech, Medicine, Allos Therapeutics, Healthcare Industry, Marketing

•••
•••
•••
•••
•••

Seattle Jobs

•••
•••
•••
•••
•••